Medical University of Vienna

🇦🇹Austria

Country: 🇦🇹Austria

Ownership: Private

Established: 1365-01-01

Employees: 1K

Market Cap: -

Website: http://www.meduniwien.ac.at

Clinical Trials

Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations

Not Applicable

Conditions: Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Familiar Hypocalcuric Hypercalcemia
Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
Healthy Volunteers

Interventions: Device: 1H/ 13C and 31P Magnetic Resonance Spectroscopy
Other: Meal Tolerance Test
Other: Hyperglycemic-hyperinsulinemic clamp

First Posted Date: 2013-12-30

Last Posted Date: 2017-03-23

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 90

Registration Number: NCT02023489

Locations: 🇦🇹
Medical University Of Vienna, Department of Internal Medicine III, Vienna, Austria

Detection of SpO2-oscillations of Low Ventilated Areas

Withdrawn

Conditions: Atelectasis

First Posted Date: 2013-12-30

Last Posted Date: 2023-03-23

Lead Sponsor: Medical University of Vienna

Registration Number: NCT02022969

Locations: 🇦🇹
MUW/AKH, Vienna, Austria

Cerebral Microembolism During Hemodialysis

Completed

Conditions: Cerebral Embolism
Complication of Dialysis
Thrombus Due to Renal Dialysis Device, Implant, or Graft

Interventions: Device: Renal hemodialysis (Fresenius 2008K, Bad Homburg, Germany)

First Posted Date: 2013-12-27

Last Posted Date: 2016-03-04

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 40

Registration Number: NCT02021045

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Cerebral Microemboli in Venoarterial ECMO Patients

Completed

Conditions: Complication of Extracorporeal Membrane Oxygenation
Cerebral Microembolism
Cerebral Perfusion

Interventions: Device: Transcranial Doppler Ultrasound

First Posted Date: 2013-12-25

Last Posted Date: 2019-05-08

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 20

Registration Number: NCT02020759

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Late Acquired Malaposition and Different Polymers

Phase 4

Completed

Conditions: Late Acquired Stent Malaposition

Interventions: Procedure: Everolimus-Eluting Stent (EES)
Procedure: Zotarolimus-Eluting-Stent (ZES)
Procedure: Biolimus-Eluting-Stent (BES)

First Posted Date: 2013-12-24

Last Posted Date: 2013-12-30

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 69

Registration Number: NCT02018991

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Multiple-dose Pharmacokinetics of Doripenem During Continuous Venovenous Hemodiafiltration and Molecular Adsorbent Recirculating System in ICU Patients and During Hemodialysis in Longterm Hemodialysis Patients.

Phase 3

Completed

Conditions: Infections During Organ Replacement Therapy

Interventions: Other: Pharmacokinetic profiling

First Posted Date: 2013-12-23

Last Posted Date: 2014-03-28

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 24

Registration Number: NCT02018939

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Surgery Versus Sclerotherapy for Isolated Accessory Great Saphenous Vein Varicosis

Phase 4

Completed

Conditions: Varicose Veins

Interventions: Procedure: surgery
Drug: sclerotherapy with aethoxysclerol foam

First Posted Date: 2013-12-13

Last Posted Date: 2013-12-13

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 40

Registration Number: NCT02010723

Locations: 🇦🇹
Medical University of Vienna, Department of General Dermatology, Vienna, Austria

Concentration of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid in the Blood During Renal Replacement Therapy in Longterm Renal Replacement Therapy Patients

Phase 3

Completed

Conditions: Infection During Hemodialysis

Interventions: Drug: Ampicillin / sulbactam
Drug: Administration of Amoxicillin / clavulanic acid
Procedure: Blooddraws for pharmacokinetic profiling

First Posted Date: 2013-12-11

Last Posted Date: 2017-05-31

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 16

Registration Number: NCT02007603

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Multiple-dose Pharmacokinetics of Ceftaroline During Continuous and Intermittent Renal Replacement Therapy in Patients Requiring Renal Replacement Therapy

Phase 4

Conditions: Infection During Renal Replacement Therapy

Interventions: Other: Ceftaroline in CRRT
Other: Ceftaroline in IRRT

First Posted Date: 2013-12-10

Last Posted Date: 2022-04-14

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 25

Registration Number: NCT02007122

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Gas Transfer on ILA-Activve

Not Applicable

Conditions: Hypercapnia

Interventions: Device: Change of blood flow or sweep gas flow ( ILA Activve)

First Posted Date: 2013-11-28

Last Posted Date: 2013-11-28

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 10

Registration Number: NCT01997528

Locations: 🇦🇹
Dept. of Medicine I, ICU, General Hospital of Vienna, Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy